Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3215]

Cytotoxic T-cells captured on film destroying cancer cells

Cytotoxic T-cells captured on film destroying cancer cells

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s

ASCO 2015: Improved care has extended the lifespan of childhood cancer survivors since the 1970s

ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

ASCO 2015: New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Circulating tumour DNA in blood predicts recurrence of common lymphoma type

Circulating tumour DNA in blood predicts recurrence of common lymphoma type

Insights into a signalling process that enhances the effectiveness of cancer immunotherapy

Insights into a signalling process that enhances the effectiveness of cancer immunotherapy

Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma

Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma

Cell movement dynamics sheds light on cancer therapy

Cell movement dynamics sheds light on cancer therapy

Discovery could help reverse glucocorticoid resistance in some young leukaemia patients

Discovery could help reverse glucocorticoid resistance in some young leukaemia patients

More from ecancer